KLRK1 and neoplasm: Then, we introduce several immune escaping strategies of tumor cells from NK cells and summarize a range of NK cell‐targeted therapeutic approaches such as adoptive NK cell therapy, CAR‐NK, and NKG2D CAR‐T cells, with an emphasis on innovative vaccines targeting MICA/B that bolster the immune response against pan‐cancers.